← FDA Drug Approvals (Drugs@FDA)
RIFAXIMIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS FL INC · Approved 2026-03-19
Drug application
- FDA Application #
ANDA208959- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RIFAXIMIN
- Generic name
- Rifaximin
- Active ingredients
- RIFAXIMIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ACTAVIS LABS FL INC
- First approval
- 2026-03-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown